Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Bulletin Du Cancer|September 26, 2020
[Dosimetric factors related to postoperative pulmonary complications in locally advanced esophageal cancers treated with preoperative chemoradiotherapy: Literature review]Marie Dworczak, Marie-Cécile Le Deley, Antoine Adenis, et al.European Urology Open Science|August 7, 2023
A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO TrialDavid Pasquier, Philippe Nickers, Didier Peiffert, et al.Frontiers in Oncology|October 9, 2023
IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret CenterThomas Le Roy, Jennifer Wallet, Maël Barthoulot, et al.Frontiers in Oncology|August 29, 2019
Chest Magnetic Resonance Imaging Decreases Inter-observer Variability of Gross Target Volume for Lung TumorsLaurent Basson, Hajer Jarraya, Alexandre Escande, et al.Journal of Pediatric Hematology/Oncology|July 1, 2010
Use of conventional fractionation with cyberknife in children: a report of 5 casesCharlotte Peugniez, Sylvain Dewas, Bernard Coche-Dequéant, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2019
A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO TrialDavid Pasquier, Didier Peiffert, Philippe Nickers, et al.Frontiers in Oncology|August 19, 2016
Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer RadiotherapyGrégory Delpon, Alexandre Escande, Timothée Ruef, et al.Plos One|December 1, 2017
Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)David Pasquier, Philippe Nickers, Didier Peiffert, et al.Radiation Oncology (London, England)|September 28, 2012
A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastasesIngrid Fumagalli, Jean-Emmanuel Bibault, Sylvain Dewas, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2008
Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II studyYazid Belkacémi, Marie-Pierre Chauvet, Sylvia Giard, et al.Pageof 8